Shanghai Medicilon

Shanghai Medicilon is a company listed under the stock ticker 688202 (CN).

View the org chart displaying its 24 main executives

Most searched biographies at Shanghai Medicilon

• Chunlin Chen, Chief Executive Officer
• Jinzhang Chen, Chairman of the Board
• Changqing Lin, Director

Popular executive movements at Shanghai Medicilon

• Haizhou Zhang has joined the company as President of Preclinical R&D Unit  (posted on January 9 2024).

Create your alert
to follow the executive moves at Shanghai Medicilon.

Shanghai Medicilon has 1,859 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member at Galenika
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Shanghai Medicilon

• A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp³-Sp² Bond Formation
• The Meaning of IND, NDA and ANDA
• Medicilon's GLP-1 New Drug R&D Service

Social media about Shanghai Medicilon

• Shanghai Medicilon on Wikipedia, Google News & Yahoo Finance
• Shanghai Medicilon on LinkedIn, Twitter & YouTube

Contact by email its executives including Chunlin Chen

Call Shanghai Medicilon at +86 215...

View the org chart

Register to receive your alert

Report an error